NCT07131046

Brief Summary

Perioperative pain management in craniotomy requires the administration of effective regional anesthetic techniques to reduce the use of systemic opioids and optimize hemodynamic control. Scalp block has been demonstrated to suppress hemodynamic response; however, its implementation generally involves a large number of injection points (six nerves that must be blocked bilaterally, resulting in a total of 12 injection points) and the possibility that not all nerve points are adequately blocked. Meanwhile, superficial cervical plexus and supraorbital block involves fewer injection points (two nerves to be blocked bilaterally, for a total of four injection points) with an analgesia area that may be sufficient to facilitate craniotomy surgery, including the insertion of Mayfield pins, consisting of only three pins, where the pin insertion area is not too large. The objective of this study is to compare the efficacy of combined superficial cervical plexus and supraorbital block with scalp block in reducing intraoperative opioid consumption and controlling hemodynamic response in craniotomy surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 18, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 9, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 9, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 28, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

August 19, 2025

Completed
Last Updated

August 19, 2025

Status Verified

August 1, 2025

Enrollment Period

3 months

First QC Date

July 28, 2025

Last Update Submit

August 18, 2025

Conditions

Keywords

superficial cervical plexus blocksupraorbital nerve blockscalp blockcraniotomyremifentanilregional anesthesia

Outcome Measures

Primary Outcomes (4)

  • Remifentanil consumption for each step of surgery

    The target effect of the highest dose of Remifentanil administered by total controlled infusion when there is an increase in MAP or heart rate by more than 20% of the initial value for 30 seconds during Mayfield pin placement, skin incision, periosteal manipulation, and skin suturing.

    intraoperative

  • The total amount of Remifentanil administered during the operation

    The total amount of remifentanil that the medical team used during the surgery

    Intraoperative

  • The greatest alterations in mean arterial pressure (MAP) during the pinning procedure, followed by skin incision, periosteum manipulation, and skin suture.

    Changes in mean arterial pressure were measured at several points: 30 minutes after the block was administered; during pin insertion; during skin incision; during periosteal incision; and during skin suturing.

    Intraoperative

  • The greatest alteration in heart rate during the pinning procedure, followed by skin incision, periosteum manipulation, and skin suture.

    Changes in heart rate were measured at several points: 30 minutes after the block was administered; during pin insertion; during skin incision; during periosteal incision; and during skin suturing.

    Intraoperative

Study Arms (2)

Combination of superficial cervical plexus block and supraorbital block

EXPERIMENTAL
Procedure: Combination of superficial cervical plexus block and supraorbital block

Scalp block

SHAM COMPARATOR
Procedure: Scalp block with bupivacaine alone

Interventions

The combined anaesthesia technique involves the use of general anaesthesia and regional block in the superficial cervical plexus and supraorbital areas, with 6 ml of 0.25% bupivacaine injected into the superficial cervical plexus area and 2 ml into the supraorbital area.

Combination of superficial cervical plexus block and supraorbital block

A combination anaesthesia technique is used that involves general anaesthesia and scalp block. Scalp block using 0.25% bupivacaine in the supraorbital area (2 ml), supratrochlear (2 ml), zygomaticotemporal (2 ml), auriculotemporal (2 ml), major occipital (2 ml) and minor occipital (2 ml).

Scalp block

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patient has been scheduled to undergo a craniotomy procedure that has been deemed medically necessary and electively scheduled. The aforementioned procedure will be performed under the administration of general anesthesia and the utilization of Mayfield pins.
  • Adult patients who have reached an age of 18 years and have not yet reached 65 years of age are included in this study.
  • Patients with ASA classification 1 - 3
  • The patient has expressed their willingness to participate in a research study and has provided their signature on an informed consent form.

You may not qualify if:

  • The patient has been diagnosed with an infection in the area where the block needle insertion is to be performed.
  • The subjects of this study were patients with a body mass index (BMI) greater than 30 kg/m2 who were classified as Grade II obese.
  • The patient is currently undergoing treatment with a beta-blocker.
  • Patients in whom intraoperative evoked potential monitoring is scheduled.
  • The patient is scheduled to undergo a total intravenous anesthesia technique
  • The history of an allergy to local anesthesia is presented before.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cipto Mangungkusoma Central Hospital

Jakarta Pusat, Jakarta Special Capital Region, 10430, Indonesia

Location

Related Publications (3)

  • Sato T, Nishiwaki K. Accuracy of landmark scalp blocks performed during asleep-awake-asleep awake craniotomy: a retrospective study. JA Clin Rep. 2021 Jan 9;7(1):8. doi: 10.1186/s40981-021-00412-4. No abstract available.

    PMID: 33420848BACKGROUND
  • Girard F, Quentin C, Charbonneau S, Ayoub C, Boudreault D, Chouinard P, Ruel M, Moumdjian R. Superficial cervical plexus block for transitional analgesia in infratentorial and occipital craniotomy: a randomized trial. Can J Anaesth. 2010 Dec;57(12):1065-70. doi: 10.1007/s12630-010-9392-3. Epub 2010 Sep 28.

    PMID: 20878375BACKGROUND
  • 1. Department of Neurology, Faculty of Medicine, Universitas Indonesia/Rumah Sakit Cipto Mangunkusumo, Jakarta, Indonesia, Aninditha T. Adults brain tumor in Cipto Mangunkusumo General Hospital: A descriptive epidemiology. Ro J Neurol. 31 Desember 2021;20(4):480-4.

    BACKGROUND

MeSH Terms

Interventions

Bupivacaine

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiologist, Principal Investigator

Study Record Dates

First Submitted

July 28, 2025

First Posted

August 19, 2025

Study Start

February 18, 2025

Primary Completion

May 9, 2025

Study Completion

May 9, 2025

Last Updated

August 19, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations